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microdissected and assayed for NPY content using a 
ispecific radioimmunoassay. 
,food and water intakes were significantly increased by 
21~ (p<O.OI) and 38% (p<O.OOI) respectively in the MA-
treated group. NPY levels were raised in the MA-treated 
'group, in the arcuate nucleus (by lQ3%, p<O.OS), the 
medial preoptic area (93%, p<O.OS), the dorsomedial 
'nucleus (92~, p<O.OS), the lateral hypothalamic area 
(122%. p<O.OS) and in the ventromedial nucleus (130~, 
p<O.OS). 
The arcuate nucleus is the main hypothalamic site of NPY 
synthesis. Increased levels in this nucleus and in the 
other regions therefore suggest increased activity of the 
NPYergic system. All these regions are sensitive to 
NPY's appetite-stimulating action, suggesting that 
increased NPY release may mediate the appetite-
stimulating effect of MA. 
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Methysergide (Meth) is a non selective 5-HT antagonist which 
stimulates feeding in rats. 5-HT has been suggested to induce satiety. 
Neuropeptide Y (NPy) is a 36 amino-acid peptide structurally related 
to pancreatic polypeptide, and one of the most abundant neuropeptide 
in the brain. 
5·HT fibres project to the hypothalamus particularly the 
paravenuicular(pYN) and arcuate (ARC) nuclei, sites of NPY action 
and synthesis respectively. 
This study set out to examine the effect of acute and chronic 
administration of methysergide on hypothalamic NPY. 
Male Wistar rats were used. In the acute experiment, rats were 
injected with either saline (0.9% n=8) or methysergide(IOmg/kg n=8) 
and killed after four hours. 
In the chronic experiment, rats were implanted with mini-osmotic 
pumps filled with either saline (n=8) or methysergide (lOmg/kg/day 
n=8). Rats were killed after seven days. 
Food intake was greater in the methysergide treated rats after four 
hours compared with the saline treated rats (p<0.01). 
NPY levels were significantly increased in the PVN and ARC in the 
methysergide treated rats (PVN 61 ± 3.2 vs 47 ± 3 fmoUug protein 
p<O.OI, ARC 49 ± 4.2 vs 27 ± 3.2 p<O.OI) 
In the chronically treated rats food intake was raised by 13% over 
seven days (p<O.O I). 
Again NPY levels were significantly increased in the methysergide 
treated rats (PVN 66 ± 6.2 vs 47 ± 3.1 fmoUug protein p=O.O I, ARC 
38.5 ± 3 vs 27.4 ± 3.2 p=O.02). 
These results suggest that methysergide induced feeding is associated 
with changesin NPYergic activity in critical hypothalamic areas. 
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Nicotine administration has an inverse relationship with body 
weight ' 
Cigarette smoking reduces food intake, and a carbohydrate-
specific craving often develops after cessation of smoking. 
The effect of nicotine administration on hypothalamiC 
Neuropeptide Y (NPy) levels, an endogenous potent appetite 
stimulant, particularly for carbohydrate was assessed in a 12 
day study in rats. 
Three groups of rats were implanted (s.c.) with mini-osmotic 
pumps, one group containing nicotine dihydrochloride (12mg/kg 
/day n=8) and two groups containing saline (0.9% n=8,8). 
The nicotine treated rats and one of the saline groups were 
allowed to free-feed for twelve days. 
The second saline treated group were pair-fed to the level of 
food intake of the nicotine treated rats. 
Food intake in the nicotine treated rats was reduced by 11 % 
over the twelve days (p=O.02), and body weight gain reduced by 
10% over the twelve days (p<O.02). 
NPY levels were significantly lower in the nicotine treated and 
pair-fed rats compared with the control rats (PVN 62 ± 6.5 vs 
91.2 ± 6.3 fmoVug protein p<0.01, ARC 33 ± 4.9 vs 49 ± 4.0 
fmol/ug protein p=0.01. pair-fed PVN 74 ± 3.7 vs 91.2 ± 6.3 
p=0.03) 
These results suggest that the hypophagia associated with 
nicotine treatment may be a result of reduced hypothalamic 
NPYergic activity. 
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Neuropeptide Y (NPy) is a potent centrally acting appet~e-stimulating 
peptide i"",licated in the regulation of energy balance. It induces 
hyperphagia and obes~y when injected into the rat hypothalamus. 
Hypothalamic NPY and NPY mRNA levels are increased in spontaneously 
obese rats. suggesting that ~ may be involved in causing obes~y in rodents. 
It is not known whether NPY has a role in the pathogenesis of obesity in 
man. NPY is found in human cerebrospinal fluid (CSF) and we have 
therefore compared CSF NPY levels in normal obese and non-obese 
individuals. to determine whether NPY concentrations might be increased in 
obesity .. 
We studied 25 clinically normal subjects (age 67 ± 5 years. male 11. 
female 14) undergoing spinal anaesthesia. None had any significant illness. 
Samples of 1 ml were freeze-dried and reconst~uted to 100 ul. and 35·ul 
aliquots were assayed for NPY using an in·house RIA. CSF NPY levels 
were not correlated w~h body mass index (BMI) (rmO.088. pmO.673) and 
there were no differences in NPY concentrations between groups of subjects 
stratified for BMI: BMI <22 (ns7), 695' n (SEM) frnoVml; BMI22-25 (n-7). 
701 ·82 fmoVml; BMI >25 (n-ll), 702' 55 fmoVml (differences between all 
groups. p><l.I). 
CSF NPY levels are therefore not increased in roman obes~y. NPY 
is found in many brain regions outside the hypothalamic appet~e-regulating 
nuclei. which could contribute to CSF levels. This negative observation does 
not therefore exclude a role of the peptide, acting specifically in the 
hypothalamus. in contributing to human obesity. 
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Neuropeptide Y (NPy) is implicated in the regulation of energy 
balance and reduces energy expenditure, by inhibiting activation of 
